, Volume 937, Issue 1, p 3
Date: 23 Jan 2013

US FDA guidance requires pharmaceutical companies to integrate race and ethnicity data into clinical trial analyses

  • show all 0 hide

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access